LAENALS: epidemiological and clinical features of amyotrophic lateral sclerosis in Latin America

References

• Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;53:17071.
   PubMed Web of Science ®Google Scholar
• van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084–98.
   PubMed Web of Science ®Google Scholar
• The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry. 1992;55:536–41.
   PubMed Web of Science ®Google Scholar
• Mitchell JD, Gatrell AC, Al-Hamad A, Davies RB, Batterby G. Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and South Cumbria. J Neurol Neurosurg Psychiatry. 1998;65:842–7.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995–1997: a population-based study. Neurology. 1999;52:504–9.
   PubMed Web of Science ®Google Scholar
• Piemonte V. d’Aosta. Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology. 2001;56:239–44.
   PubMed Web of Science ®Google Scholar
• Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor nueron disease in Scotland. J Neurol. 2007;254:866–9.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in Southern Italy: a population based study. J Neurol Neurosurg Psychiatry. 2005;76:1094–8.
   PubMed Web of Science ®Google Scholar
• Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G, SLALOM Group. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141–5.
   PubMed Web of Science ®Google Scholar
• O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30–2.
   PubMed Web of Science ®Google Scholar
• Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68:1002–7.
   PubMed Web of Science ®Google Scholar
• Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009;72:1640–5.
   PubMed Web of Science ®Google Scholar
• Valenzuela D, Zitko P, Lillo P. Amyotrophic lateral sclerosis mortality rates in Chile: a population based study (1994–2010). Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:372–7.
   PubMed Web of Science ®Google Scholar
• Bucheli M, Andino A, Montalvo M, Cruz J, Atassi N, Berry J, et al. Amyotrophic lateral sclerosis: analysis of ALS cases in a predominantly admixed population of Ecuador. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:106–13.
   PubMed Web of Science ®Google Scholar
• Mehta P, Raymond J, Punjani R, Larson T, Bove F, Kaye W, et al. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:220–5.
   PubMed Web of Science ®Google Scholar
• Hardiman O, Heverin M, Rooney J, Lillo P, Godoy G, Sáez D, et al. The Latin American Epidemiology Network for ALS (Laenals). Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:372–7.
   PubMed Web of Science ®Google Scholar
• D'Ovidio F, Rooney JPK, Visser AE, Vermeulen RCH, Veldink JH, Van Den Berg LH, et al. Critical issues in ALS case–control studies: the case of the Euro-MOTOR study. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:411–8.
   PubMed Web of Science ®Google Scholar
• Latinobarometro [Internet] [cited 2023 May 11]. Available from: https://www.latinobarometro.org/lat.jsp
   Google Scholar
• Marcheco-Teruel B, Parra EJ, Fuentes-Smith E, Salas A, Buttenschøn HN, Demontis D, et al. Cuba: exploring the history of admixture and the genetic basis of pigmentation using autosomal and uniparental markers. PLoS Genet. 2014;10:e1004488.
   PubMed Web of Science ®Google Scholar
• Cabrera-Gómez JA, Kurtzke JF, González-Quevedo A, Lara-Rodríguez R. An epidemiological study of neuromyelitis optica in Cuba. J Neurol. 2009;256:35–44.
   PubMed Web of Science ®Google Scholar
• Sans M, Merriwether DA, Hidalgo PC, Bentancor N, Weimer TA, Franco MHLP, et al. Population structure and admixture in Cerro Largo, Uruguay, based on blood markers and mitochondrial DNA polymorphisms. Am J Hum Biol. 2006;18:513–24.
   PubMed Web of Science ®Google Scholar
• Data Catalog [Internet]. [cited 2023 May 11]. Available from: https://datacatalog.worldbank.org
   Google Scholar
• Repositorio Cepal [Internet]. [cited 2023 May 11]. Available from: https://repositorio.cepal.org/bitstream/handle/11362/41018/S1600734_en.pdf?sequence=1&isAllowed=y
   Google Scholar
• World Bank Open Data [Internet]. [cited 2023 Sep 10]. World Bank Open Data. Available from: https://data.worldbank.org
   Google Scholar
• Marin B, Fontana A, Arcuti S, Copetti M, Boumédiene F, Couratier P, et al. Age-specific ALS incidence: a dose–response meta-analysis. Eur J Epidemiol. 2018;33:621–34.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. 2014;13:1108–13.
   PubMed Web of Science ®Google Scholar
• Gwinn-Hardy K. Racial and ethnic influences on the expression of the genotype in neurodegenerative diseases. In: Genotype–proteotype–phenotype relationships in neurodegenerative diseases. Paris: Springer; 2005:27–36.
   Google Scholar
• Census, race and science. Nat Genet. 2000;24:97–8.
   PubMed Web of Science ®Google Scholar
• Luna J, Logroscino G, Couratier P, Marin B. Current issues in ALS epidemiology: variation of ALS occurrence between populations and physical activity as a risk factor. Rev Neurol (Paris). 2017;173:244–53.
   PubMed Web of Science ®Google Scholar
• Cooper RS, Kennelly JF, Orduñez-Garcia P. Health in Cuba. Int J Epidemiol. 2006;35:817–24.
   PubMed Web of Science ®Google Scholar
• Meerman J. Poverty and mobility in low status minorities: the Cuban case in international perspective. World Develop. 2001;29:1457–81.
   Web of Science ®Google Scholar
• GBD 2016 Motor Neuron Disease Collaborators Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:1083–97.
   PubMed Web of Science ®Google Scholar
• F L, A B, H G, W S. Epidemiology of motor neuron disease in Northern Sweden. Acta Neurol Scand. [Internet] 1983;68 [cited 2023 May 12]. Available from: https://pubmed.ncbi.nlm.nih.gov/6604389/
   Google Scholar
• M B, H B, C P, N M, D A, R M, et al. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe–the French register of ALS in Limousin (FRALim register). Eur J Neurol. 2014;21. [Internet]. Oct [cited 2023 May 12]. Available from: https://pubmed.ncbi.nlm.nih.gov/24909935/
   Web of Science ®Google Scholar
• Wolf J, Wöhrle JC, Palm F, Nix WA, Maschke M, Safer A, et al. Incidence of amyotrophic lateral sclerosis in Rhineland–Palatinate, Germany. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:269–74.
   PubMed Web of Science ®Google Scholar
• Uenal H, Rosenbohm A, Kufeldt J, Weydt P, Goder K, Ludolph A, et al. Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany–completeness of the ALS registry Swabia. PloS One. 2014;9:e93932.
   PubMed Web of Science ®Google Scholar
• Pugliatti M, Parish LD, Cossu P, Leoni S, Ticca A, Saddi MV, et al. Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009. J Neurol. 2013;260:572–9.
   PubMed Web of Science ®Google Scholar
• Pradas J, Puig T, Rojas-García R, Viguera ML, Gich I, Logroscino G. Amyotrophic lateral sclerosis in Catalonia: a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:278–83.
   PubMed Web of Science ®Google Scholar
• Chiò A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology. 2009;72:725–31.
   PubMed Web of Science ®Google Scholar
• Rooney J, Byrne S, Heverin M, Corr B, Elamin M, Staines A, et al. Survival analysis of Irish amyotrophic lateral sclerosis patients diagnosed from 1995–2010. PloS One. 2013;8:e74733.
   PubMed Web of Science ®Google Scholar
• Drigo D, Verriello L, Clagnan E, Eleopra R, Pizzolato G, Bratina A, et al. The incidence of amyotrophic lateral sclerosis in Friuli Venezia Giulia, Italy, from 2002 to 2009: a retrospective population-based study. Neuroepidemiology. 2013;41:54–61.
   PubMed Web of Science ®Google Scholar
• Mandrioli J, Biguzzi S, Guidi C, Venturini E, Sette E, Terlizzi E, et al. Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:262–8.
   PubMed Web of Science ®Google Scholar
• Joensen P. Incidence of amyotrophic lateral sclerosis in the Faroe Islands. Acta Neurol Scand. 2012;126:62–6.
   PubMed Web of Science ®Google Scholar
• Imam I, Ball S, Wright D, Hanemann CO, Zajicek J. The epidemiology of motor neurone disease in two countries in the Southwest of England. J Neurol. 2010;257:977–81.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
   PubMed Web of Science ®Google Scholar
• Chiò A, Calvo A, Moglia C, Mazzini L, Mora G, PARALS Study Group. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82:740–6.
   PubMed Web of Science ®Google Scholar
• Gross-Paju K, Oöpik M, Lüüs SM, Kalbe I, Puksa L, Lepik T, et al. Motor neurone disease in South Estonia. Diagnosis and incidence rate. Acta Neurol Scand. 1998;98:22–8.
   PubMed Web of Science ®Google Scholar
• Bandettini di Poggio M, Sormani MP, Truffelli R, Mandich P, Origone P, Verdiani S, et al. Clinical epidemiology of ALS in Liguria, Italy. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:52–7.
   PubMed Web of Science ®Google Scholar
• Forbes RB, Colville S, Cran GW, Swingler RJ, Scottish Motor Neurone Disease Register. Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. J Neurol Neurosurg Psychiatry. 2004;75:1753–5.
   PubMed Web of Science ®Google Scholar